Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Evaluation of the pharmacodynamic profile (antiaggregant profile, balance of prostanoids and
nitric oxid) of a ASA-SR (slow-release)formulation in comparison with a ASA NR (normal
release), 150 mg, during 12 months of treatment.